Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (187) clinical trials

Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population

Diabetic nephropathy (DN) is a common vascular complication of Type 2 diabetes (T2D) that is associated with increased mortality and poor quality of life.In industrialized countries, DN ranges first among other etiologies of end-stage renal disease (ESRD).Diabetes in Qatar is a serious health issue for the Qatari population since approximately ...

Phase N/A

Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and Endocrinologists

Study design: This is a multi-centre observational, ambispective study, which will retrospectively and prospectively collect clinical variables and socio-demographic data from medical records of patients with T2DM initiated with dapagliflozin by GPs and endocrinologists in real-life setting. Only patients, who provide written consent to participate in the study will be ...

Phase N/A

Microvascular Blood Flow and Metabolic Flexibility in Hispanics

Metabolic disease, including type 2 diabetes (T2D) and pre-diabetes is a significant health issue globally, particularly in the Hispanic population. The impact of this disease on morbidity and mortality is unquestionable, as it is associated with various aspects of neural and cardiovascular disease. The incidence of T2D is continually increasing, ...

Phase N/A

Mitigation of Type 2 Diabetes by Partial Ileal Bypass

The partial ileal bypass (PIB) operation is a standard procedure used in the management of hyperlipidmia since 1963. POSCH was the intervention modality in the National Institutes of Health, National Heart Lung and Blood Institute-funded Program on the Surgical Control of the Hyperlipidemias (POSCH) trial. The POSCH study was a ...

Phase N/A

The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes

Background Mortality rate of diabetic patients is about twice as much that of non-diabetic individuals of similar age; this makes diabetes a leading risk factor for mortality, especially of cardiovascular origin, which accounts for 2.9 million global events yearly. Such scenario is expected to further deteriorate, given that the prevalence ...

Phase N/A

Pathways for Health Equity Quality Improvement Strategy

GOAL To improve the health and health equity of Indigenous peoples by strengthening the effectiveness, sustainability and scalability of a promising community-driven and culturally-relevant quality improvement strategy through meaningful conversations and engagement with our community partners. OBJECTIVES Engage community partners and key stakeholders to support meaningful participation and leadership Review, ...

Phase N/A

DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes

The global prevalence of Type 2 Diabetes (T2D) is rapidly rising throughout most regions of the developed and developing world. In Middle East countries, particularly in the Gulf Council countries, the diabetes pandemic along with the rates of obesity have risen due to the adoption of a modern lifestyle. In ...

Phase N/A

XIGDUO Extended Release (XR) Post Marketing Surveillance

Primary objective: Descriptive analysis of the proportion (%) of adverse events (AEs), serious adverse events (SAEs), unexpected adverse eventsadverse drug reactions and AEs of special interest (AESI) in patients who are treated with Xigduo XR for type 2 diabetes mellitus by physicians in the normal clinical practice setting over a ...

Phase N/A

Study With Dapagliflozin

Objectives and Hypotheses: Primary objective: To describe HbA1c (glycosylated haemoglobin) change from baseline to follow-up Secondary objectives: Clinical data: To estimate percentage (%) of patients with reduction of HbA1c by 0.5% or more from baseline to follow-up To estimate percentage (%) of patients reaching the therapeutic glycemic response (HbA1c <7.0%) ...

Phase N/A

Evaluating for Type-2 Diabetes in the Very Early Postpartum Period

This will be a prospective cohort study conducted at Winthrop-University Hospital. Women 18 years old or older who delivered a child or fetus within the previous 4 days at either hospital who also were diagnosed with GDM during the pregnancy will be eligible for participation. Women will be excluded if ...

Phase N/A